TOP3A is underexpressed in ovarian cancer, and mutations in TOP3A are associated with increased risk for acute myeloid leukemia and myelodysplastic syndromes, suggesting potential cancer vulnerabilities if somatic, but they can also occur in the germline, which would lead to enhanced host toxicity [63,64,65]. Here, TOP3A is linked to cancer.